Biohaven pharmaceutical Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Biohaven pharmaceutical Contact Number

Contact Us Contact Us. Our Office. Biohaven Pharmaceuticals Holding Company Ltd. C/O Biohaven Pharmaceuticals, Inc. 215 Church Street New Haven, CT 06510. If you are a patient, caregiver, or healthcare provider with a question regarding Nurtec ODT, please

Contact US: https://www.biohavenpharma.com/contact-us

Who is biohaven pharmaceutical holding company ltd bhvn?

NEW HAVEN, Conn., Aug. 14, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders, today reported...

Where is biohaven located?

Biohaven Pharmaceutical headquarters is located at 215 Church St, New Haven. Where are Biohaven Pharmaceutical offices? Biohaven Pharmaceutical has an office in New Haven. How many offices does Biohaven Pharmaceutical have? Biohaven Pharmaceutical has 1 office.

How can i get in contact with biohaven?

If you prefer to be contacted by phone, please enter it below. Please enter your question or inquiry below.* By registering, you agree to receive information from Biohaven via the contact information you provided. You may also be contacted for optional participation in market research and the development of programs and services.

Who are biohavens competitors?

Competitors of Biohaven Pharmaceutical include U.S. Stem Cell, Cannabis Sativa and Endologix. Where is Biohaven Pharmaceutical headquarters? Biohaven Pharmaceutical headquarters is located at 215 Church St, New Haven. Where are Biohaven Pharmaceutical offices? Biohaven Pharmaceutical has an office in New Haven.

Found

43 People Used

See More ››

Biohaven Pharmaceuticals

Found. The document has moved here.

View Contact ››

Office

53 People Used

See More ››

Biohaven Pharmaceutical Corporate Headquarters, Office

Biohaven Pharmaceutical is headquartered in New Haven, CT and has 1 office location across 1 country. See the full list at Craft.

View Contact ››

Biohaven

44 People Used

See More ››

Biohaven Pharmaceutical Company Profile

Biohaven Pharmaceutical has 838 employees at their 1 location and $80 m in total funding,. See insights on Biohaven Pharmaceutical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

View Contact ››

·

54 People Used

See More ››

Biohaven Pharmaceuticals

Biohaven Pharmaceuticals. 1,224 likes · 167 talking about this · 2 were here. Clinical stage biopharmaceutical company with innovative drug candidates targeting neurological diseases.

View Contact ››

Biohaven''s

86 People Used

See More ››

Biohaven Pharmaceutical Holding

Biohaven''s BHV-1200, A Multimodal Antibody Therapy Enhancer (MATE), Demonstrates Effective Neutralization Of Multiple Strains Of COVID-19 NEW HAVEN, Conn., Feb. 22, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates, today …

View Contact ››

Seasoned

68 People Used

See More ››

Board of Directors Biohaven Pharmaceuticals

Dr. Doogan is a seasoned drug development executive and life sciences investor with more than 30 years experience in the global pharmaceutical industry. He joined Pfizer in 1982, where he held a number of senior positions in R&D in the USA, UK and Japan. Dr.

View Contact ››

BIOHAVEN

66 People Used

See More ››

RxAssist

BIOHAVEN PHARMACEUTICALS Patient Assistance Program. Patient assistance programs (PAPs) are programs created by drug companies, such as BIOHAVEN PHARMACEUTICALS, to offer free or low cost drugs to individuals who are unable to pay for their medication.

View Contact ››

Number

72 People Used

See More ››

Biohaven Pharmaceutical

Number of Exits 1 Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders.

View Contact ››

Biohaven

104 People Used

See More ››

Biohaven Highlights Neuroscience Advancements with 22

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that 22 abstracts, including three oral presentations, were accepted at the 2021 American Academy of Neurology (AAN

View Contact ››

Found

57 People Used

See More ››

Biohaven Pharma

Found. The document has moved here.

View Contact ››

Please leave your comments here:

Popular Brands

Bce
Brf
Bmw
Bvb
Bpost